Cargando…
Cinacalcet in Patients with Chronic Kidney Disease: A Cumulative Meta-Analysis of Randomized Controlled Trials
BACKGROUND: Calcimimetic agents lower serum parathyroid hormone levels in people with chronic kidney disease (CKD), but treatment effects on patient-relevant outcomes are uncertain. We conducted a systematic review and meta-analysis to summarize the benefits and harms of calcimimetic therapy in adul...
Autores principales: | Palmer, Suetonia C., Nistor, Ionut, Craig, Jonathan C., Pellegrini, Fabio, Messa, Piergiorgio, Tonelli, Marcello, Covic, Adrian, Strippoli, Giovanni F. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3640084/ https://www.ncbi.nlm.nih.gov/pubmed/23637579 http://dx.doi.org/10.1371/journal.pmed.1001436 |
Ejemplares similares
-
Heart Failure in Patients with Chronic Kidney Disease: A Systematic Integrative Review
por: Segall, Liviu, et al.
Publicado: (2014) -
Vitamin K supplementation impact in dialysis patients: a systematic review and meta-analysis of randomized trials
por: Andrian, Titus, et al.
Publicado: (2023) -
Clinical Implications and Risk Factors for Erectile Dysfunction in Kidney Transplant: A Single-Center Assessment
por: Miron, Adelina, et al.
Publicado: (2023) -
HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis
por: Palmer, Suetonia C., et al.
Publicado: (2015) -
HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis
por: Palmer, Suetonia C., et al.
Publicado: (2014)